VCAP-AMP-VECP regimen

WikiDoc Resources for VCAP-AMP-VECP regimen
Articles
Most recent articles on VCAP-AMP-VECP regimen Most cited articles on VCAP-AMP-VECP regimen Review articles on VCAP-AMP-VECP regimen Articles on VCAP-AMP-VECP regimen in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on VCAP-AMP-VECP regimen Images of VCAP-AMP-VECP regimen Photos of VCAP-AMP-VECP regimen Podcasts & MP3s on VCAP-AMP-VECP regimen Videos on VCAP-AMP-VECP regimen
Evidence Based Medicine
Cochrane Collaboration on VCAP-AMP-VECP regimen Bandolier on VCAP-AMP-VECP regimen TRIP on VCAP-AMP-VECP regimen
Clinical Trials
Ongoing Trials on VCAP-AMP-VECP regimen at Clinical Trials.gov Trial results on VCAP-AMP-VECP regimen Clinical Trials on VCAP-AMP-VECP regimen at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on VCAP-AMP-VECP regimen NICE Guidance on VCAP-AMP-VECP regimen NHS PRODIGY Guidance FDA on VCAP-AMP-VECP regimen CDC on VCAP-AMP-VECP regimen
Books
Books on VCAP-AMP-VECP regimen
News
VCAP-AMP-VECP regimen in the news Be alerted to news on VCAP-AMP-VECP regimen News trends on VCAP-AMP-VECP regimen
Commentary
Blogs on VCAP-AMP-VECP regimen
Definitions
Definitions of VCAP-AMP-VECP regimen
Patient Resources / Community
Patient resources on VCAP-AMP-VECP regimen Discussion groups on VCAP-AMP-VECP regimen Patient Handouts on VCAP-AMP-VECP regimen Directions to Hospitals Treating VCAP-AMP-VECP regimen Risk calculators and risk factors for VCAP-AMP-VECP regimen
Healthcare Provider Resources
Symptoms of VCAP-AMP-VECP regimen Causes & Risk Factors for VCAP-AMP-VECP regimen Diagnostic studies for VCAP-AMP-VECP regimen Treatment of VCAP-AMP-VECP regimen
Continuing Medical Education (CME)
CME Programs on VCAP-AMP-VECP regimen
International
VCAP-AMP-VECP regimen en Espanol VCAP-AMP-VECP regimen en Francais
Business
VCAP-AMP-VECP regimen in the Marketplace Patents on VCAP-AMP-VECP regimen
Experimental / Informatics
List of terms related to VCAP-AMP-VECP regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Overview

VCAP-AMP-VECP regimen refers to a regimen consisting of with vincristine, cyclophosphamide, doxorubicin (adriamycin), and prednisone (VCAP), doxorubicin (adriamycin), ranimustine, and prednisone (AMP), and vindesine, etoposide, carboplatin, and prednisone (VECP) used to treat human T-lymphotropic virus type I-associated adult T-cell leukemia-lymphoma (ATLL)

Regimen

VVincristine CCyclophosphamide ADoxorubicin (Adriamycin) {{chemo|P|Prednisone}

ADoxorubicin (Adriamycin)

MRanimustine (MCNU)

PPrednisone

VVindesine

EEtoposide

CCarboplatin

PPrednisone

Indications

• Human T-lymphotropic virus type I-associated Adult T-cell leukemia-lymphoma (ATLL)